Factors influencing antenatal corticosteroid administration for management of women imminent preterm birth: A cross-sectional study in two Kenyan county referral hospitals
DOI:
https://doi.org/10.51867/ajernet.7.2.90Keywords:
Antenatal Corticosteroids, Cross-Sectional Study, Facility Factors, Healthcare Providers, Kenya, Preterm BirthAbstract
Antenatal corticosteroids (ACS) are an established, evidence-based intervention that significantly reduces morbidity and mortality associated with prematurity. However, despite strong global recommendations, including those from the World Health Organization (WHO), their utilization remains suboptimal in low- and middle-income countries (LMICs), where the burden of neonatal deaths is highest. Understanding the determinants of ACS use is therefore critical for improving implementation. This study was primarily guided by the Donabedian Model, which examines healthcare quality through structure, process, and outcomes. A cross-sectional design was employed between June and August 2025 at Nyahururu County Referral Hospital (Laikipia County) and Wamalwa Kijana County Referral Hospital (Trans Nzoia County). The study included 160 healthcare providers (80 per facility) involved in maternal and newborn care. Data were collected using structured questionnaires covering demographics, knowledge (20 items), practices (15 items), and perceived facility-level factors (10 items). Additionally, a data extraction tool was used to get information from the records of the 160 preterm birth cases that were conducted. A data extraction form was used to do record review, which was done to obtain information regarding preterm birth (n=160). Quantitative data were analyzed using chi-square tests, independent t-tests, and bivariate and multivariable logistic regression, while qualitative insights were obtained through thematic analysis of eight key informant interviews. Thematic analysis of key informant interviews (n=8) provided complementary qualitative insights. The mean knowledge score was 55.2% (SD 20.7), with only 49.4% of providers correctly identifying ACS indications and 46.9% knowing WHO-recommended gestational age. ACS was administered to only 30.6% (49/160) of eligible women. The primary reason for non-administration was failure to prescribe (82.5% of missed cases). Facility-level factors significantly associated with ACS administration included availability of visible standard operating procedures (adjusted OR [aOR]: 2.34, 95% CI: 1.28-4.27, p=0.006), access to WHO guidelines (aOR: 1.89, 95% CI: 1.04-3.43, p=0.037), and prior training on evidence-based practices including ACS (aOR: 2.67, 95% CI: 1.41-5.06, p=0.002). Provider knowledge score was associated in bivariate analysis (p=0.018) but not after adjusting for facility factors (aOR: 1.02, p=0.412). Qualitative findings revealed four major themes: knowledge and practice gaps, challenges in identifying eligible clients, lack of accessible guidelines and protocols, and inconsistent administration practices. Facility-level system factors, particularly visible protocols, guideline accessibility, and provider training, are stronger predictors of ACS administration than individual provider knowledge alone. Interventions to improve ACS utilization in resource-limited settings should prioritize system-level changes alongside educational programs. Policy recommendation: Hospital administrators and county health management teams should provide necessary facility-level actors, including displaying visible standard operating procedures (SOPs), ensuring accessible WHO guidelines, and supporting the Kenyan Ministry of Health (MOH) to implement regular evidence-based practice training, integrate ACS administration indicators, and develop a national ACS clinical decision support tool.
Downloads
References
Alamneh, T. S., Teshale, A. B., Worku, M. G., Tessema, Z. T., Yeshaw, Y., Tesema, G. A., Liyew, A. M., & Alem, A. Z. (2021). Preterm birth and its associated factors among reproductive aged women in sub-Saharan Africa: Evidence from the recent demographic and health surveys of sub-Saharan African countries. BMC Pregnancy and Childbirth, 21(1), 1-11. https://doi.org/10.1186/s12884-021-04233-2
Busuulwa, P., Groom, K., Chappell, L. C., & Shennan, A. H. (2021). The role of antenatal corticosteroids in improving neonatal outcomes. The Obstetrician & Gynaecologist, 23(4), 246-257.
https://doi.org/10.1111/tog.12768
Costa, D., Costa, A. D., Oladapo, O. T., Gupta, S., Portela, A., Vogel, J. P., Souza, J. P., Rao, S., Minckas, N., Tunçalp, Ö., Bahl, R., & Althabe, F. (2022). Antenatal corticosteroids for early preterm birth: Implementation strategy lessons from the WHO ACTION-I trial. Health Research Policy and Systems, 20(1), 1-6. https://doi.org/10.1186/s12961-022-00941-z
Dagklis, T., Sen, C., Tsakiridis, I., Villalaín, C., Allegaert, K., Wellmann, S., Kusuda, S., Serra, B., Luna, M. S., Huertas, E., Volpe, N., Ayala, R., Jekova, N., Grunebaum, A., & Stanojevic, M. (2022). The use of antenatal corticosteroids for fetal maturation: Clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation. Journal of Perinatal Medicine, 50(4), 375-385. https://doi.org/10.1515/jpm-2022-0066
Eddy, K. E., Vogel, J. P., Scott, N., Fetene, D., Tidhar, T., Oladapo, O. T., Piaggio, G., Nguyen, M. H., Althabe, F., Bahl, R., Rao, S. P. N., Costa, A. D., Gupta, S., Baqui, A. H., Shahidullah, M., Chowdhury, S. B., Ahmed, S., Sultana, S., Jaben, I. A., … Raza, F. (2022). Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: A cost-effectiveness analysis of the WHO ACTION-I trial. The Lancet Global Health, 10(10), e1523-e1533. https://doi.org/10.1016/S2214-109X(22)00340-0
Ekitela, L., Kibiwott, D., Wanyama, L. N., & Kibii, I. J. (2023). Survival determinants of preterm infants in a neonatal care unit at a tertiary hospital in Kenya. East African Journal of Nursing, 1(1), Article 1. https://doi.org/10.58460/eajn.v1i01.79
Greensides, D., Robb-McCord, J., Noriega, A., & Litch, A. (2018). Antenatal corticosteroids for women at risk of imminent preterm birth in 7 sub-Saharan African countries: A policy and implementation landscape analysis, 644-656. https://doi.org/10.9745/GHSP-D-18-00171
Isangula, K., Mbekenga, C., Mwansisya, T., Mwasha, L., Kisaka, L., Selestine, E., Siso, D., Rutachunzibwa, T., Mrema, S., & Pallangyo, E. (2022). Healthcare providers' experiences with a clinical mentorship intervention to improve reproductive, maternal and newborn care in Mwanza, Tanzania. Frontiers in Health Services, 2, 792909. https://doi.org/10.3389/frhs.2022.792909
Islamiah, R., Vogel, J. P., Minckas, N., Althabe, F., Oladapo, O. T., & Bohren, M. A. (2022). Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis. PLOS Medicine, 19(8), e1004074. https://doi.org/10.1371/journal.pmed.1004074
Jacobsson, B., Requejo, J. H., Dey, T., Lavin, T., Mannah, M. T., Menon, R., Valencia, C., Sharma, G., Shennan, A., Shakibazadeh, E., Lumbiganon, P., Bar-Zeev, S., Steen, S., Nguku, A., Obara, H., Noguchi, L., Okong, P., Singh, S. A., Sandall, J., … Vogel, J. P. (2025). Born too soon: Women's health and maternal care services, seizing missed opportunities to prevent and manage preterm birth. Reproductive Health, 22(2), 109. https://doi.org/10.1186/s12978-025-02034-w
Kenya National Bureau of Statistics (KNBS), & ICF. (2023). Kenya demographic and health survey 2022. KNBS and ICF.
Kibanga, W., Mutagonda, R. F., Moshiro, R., Mareale, A., Kilonzi, M., Mlyuka, H. J., Mikomangwa, W. P., Kunambi, P. P., Kamuhabwa, A., & Minzi, O. M. (2023). Effectiveness of antenatal dexamethasone in reducing respiratory distress syndrome and mortality in preterm neonates: A nested case-control study. BMC Pediatrics, 23(1), 94. https://doi.org/10.1186/s12887-023-03887-5
Lv, G., & Ming, C. (2022). Efficacy and safety of leflunomide combined with corticosteroids for the treatment of IgA nephropathy: A meta-analysis of randomized controlled trials. Renal Failure, 44(1), 1012-1026. https://doi.org/10.1080/0886022X.2022.2085576
Mpinga, G., Al-Beity, F. M. A., & Manji, K. (2023). Antenatal corticosteroid and early neonatal outcomes among preterm neonates delivered at a tertiary hospital in Tanzania. African Journal of Reproductive Health, 27(7), Article 7. https://doi.org/10.29063/ajrh2023/v27i7.3
Mwita, S., Jande, M., Katabalo, D., Kamala, B., & Dewey, D. (2021). Reducing neonatal mortality and respiratory distress syndrome associated with preterm birth: A scoping review on the impact of antenatal corticosteroids in low- and middle-income countries. World Journal of Pediatrics, 17(2), 131-140. https://doi.org/10.1007/s12519-020-00398-6
Mworia, A. (2022). Utilization of antenatal corticosteroids for improving neonatal outcomes in Kenyatta National Hospital [Master's thesis, University of Nairobi]. http://erepository.uonbi.ac.ke/handle/11295/161555
Ndwiga, E. W., Keraka, M., & Kodhiambo, M. (2023). Health facility factors influencing the implementation of PTBI during the provision of intrapartum and perinatal care in Embu County. Edith Cowan Journal of Medicine, Nursing and Public Health, 6(1), 1-12. https://doi.org/10.55077/edithcowanjournalofmedicinenursingandpublichealth.v6i1.51
Ngare, B. K., Ronoh, Y., Owiny, M., Gesare, C., & Gura, Z. (2020). Perinatal mortality in emergency obstetric health care facilities, Nakuru County, Kenya, 2014-2017: A descriptive cross-sectional surveillance data analysis. Journal of Interventional Epidemiology and Public Health, 3(2), Article 2. https://www.ajol.info/index.php/jieph/article/view/223912
https://doi.org/10.37432/jieph.2020.3.4.29
World Health Organization. (2022). WHO recommendations on antenatal corticosteroids for improving preterm birth outcomes. World Health Organization.
Rizzo, G., Mappa, I., Bitsadze, V., Khizroeva, J., Makatsariya, A., & D'Antonio, F. (2022). Administration of antenatal corticosteroid is associated with reduced fetal growth velocity: A longitudinal study. The Journal of Maternal-Fetal & Neonatal Medicine, 35(14), 2775-2780. https://doi.org/10.1080/14767058.2020.1800634
Shittu, K. A., Ahmed, B., Rabiu, K. A., Akinlusi, F., & Akinola, O. I. (2024). Does the use of antenatal corticosteroids reduce respiratory morbidity in babies born in late preterm period? BMC Pregnancy and Childbirth, 24(1), 334. https://doi.org/10.1186/s12884-024-06304-6
Smith, J., Murphy, K. E., McDonald, S. D., Asztalos, E., Aviram, A., Ronzoni, S., Mei-Dan, E., Zaltz, A., Barrett, J., & Melamed, N. (2022). Timing of antenatal corticosteroids in relation to clinical indication. Archives of Gynecology and Obstetrics, 306(4), 997-1005. https://doi.org/10.1007/s00404-021-06362-7
Stock, S., Thomson, A., & Papworth, S. (2022). Antenatal corticosteroids to reduce neonatal morbidity and mortality: Green-top Guideline No. 74. BJOG: An International Journal of Obstetrics & Gynaecology, 129(8), e35-e60. https://doi.org/10.1111/1471-0528.17027
Swarray-Deen, A., Sepenu, P., Mensah, T. E., Osei-Agyapong, J., Sefogah, P. E., Appiah-Sakyi, K., Ahmed, B., & Konje, J. C. (2024). Preterm birth in low-middle income countries. Best Practice & Research Clinical Obstetrics & Gynaecology, 95, 102518. https://doi.org/10.1016/j.bpobgyn.2024.102518
Vogel, J. P., Ramson, J., Darmstadt, G. L., Qureshi, Z. P., Chou, D., Bahl, R., & Oladapo, O. T. (2022). Updated WHO recommendations on antenatal corticosteroids and tocolytic therapy for improving preterm birth outcomes. The Lancet Global Health, 10(12), e1707-e1708. https://doi.org/10.1016/S2214-109X(22)00434-X
Yang, W.-C., Getachew, T., Smith, E. R., Bekele, D., Haile, S., Metaferia, G., Tilahun, Z. B., & Arsenault, C. (2025). Barriers to improving preterm newborn outcomes through effective antenatal corticosteroid use in Ethiopia. BMJ Global Health, 10(9), e019102. https://doi.org/10.1136/bmjgh-2025-019102
Zahroh, R. I., Hazfiarini, A., Eddy, K. E., Vogel, J. P., Tunçalp, Ö., Minckas, N., Althabe, F., Oladapo, O. T., & Bohren, M. A. (2022). Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis. PLOS Medicine, 19(8), e1004074. https://doi.org/10.1371/journal.pmed.1004074
Zahroh, R. I., Hazfiarini, A., Eddy, K. E., Vogel, J. P., Tunçalp, Ö., Minckas, N., Althabe, F., Oladapo, O. T., & Bohren, M. A. (2022). Factors influencing appropriate use of interventions for management of women experiencing preterm birth: A mixed-methods systematic review and narrative synthesis. PLOS Medicine, 19(8), e1004074. https://doi.org/10.1371/journal.pmed.1004074
Zipori, Y., Zidan, R., Lauterbach, R., Hagag, A., Ginsberg, Y., Solt, I., Weiner, Z., Kugelman, A., & Beloosesky, R. (2021). Antenatal betamethasone and the risk of neonatal hypoglycemia: It's all about timing. Archives of Gynecology and Obstetrics, 303(3), 695-701. https://doi.org/10.1007/s00404-020-05785-y
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Irene Jepkemei Chirchir, Prof. Mary Kipmerewo, Prof. Charles Mutai, Dr. Sally Oronje

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.













